Ptc Therapeutics (PTCT) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Ptc Therapeutics (PTCT) over the last 14 years, with Q3 2025 value amounting to $6.5 million.
- Ptc Therapeutics' Non Operating Income rose 44732.91% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 8012.73%. This contributed to the annual value of $6.5 million for FY2024, which is 3539.98% down from last year.
- Ptc Therapeutics' Non Operating Income amounted to $6.5 million in Q3 2025, which was up 44732.91% from -$5.7 million recorded in Q2 2025.
- Ptc Therapeutics' Non Operating Income's 5-year high stood at $35.1 million during Q4 2022, with a 5-year trough of -$38.1 million in Q3 2022.
- For the 5-year period, Ptc Therapeutics' Non Operating Income averaged around -$5.0 million, with its median value being -$2.0 million (2024).
- As far as peak fluctuations go, Ptc Therapeutics' Non Operating Income tumbled by 118381.7% in 2022, and later skyrocketed by 44732.91% in 2025.
- Ptc Therapeutics' Non Operating Income (Quarter) stood at -$31.4 million in 2021, then surged by 212.02% to $35.1 million in 2022, then crashed by 46.05% to $19.0 million in 2023, then plummeted by 53.33% to $8.8 million in 2024, then decreased by 26.53% to $6.5 million in 2025.
- Its last three reported values are $6.5 million in Q3 2025, -$5.7 million for Q2 2025, and -$6.3 million during Q1 2025.